135 related articles for article (PubMed ID: 20847417)
1. Oren-gedoku-to and its constituents with therapeutic potential in Alzheimer's disease inhibit indoleamine 2, 3-dioxygenase activity in vitro.
Yu CJ; Zheng MF; Kuang CX; Huang WD; Yang Q
J Alzheimers Dis; 2010; 22(1):257-66. PubMed ID: 20847417
[TBL] [Abstract][Full Text] [Related]
2. The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
Yu D; Tao BB; Yang YY; Du LS; Yang SS; He XJ; Zhu YW; Yan JK; Yang Q
J Alzheimers Dis; 2015; 43(1):291-302. PubMed ID: 25079795
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1-42: implications for the pathogenesis of Alzheimer's disease.
Yamada A; Akimoto H; Kagawa S; Guillemin GJ; Takikawa O
J Neurochem; 2009 Aug; 110(3):791-800. PubMed ID: 19457071
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus.
Guillemin GJ; Brew BJ; Noonan CE; Takikawa O; Cullen KM
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):395-404. PubMed ID: 16008823
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast.
Vottero E; Balgi A; Woods K; Tugendreich S; Melese T; Andersen RJ; Mauk AG; Roberge M
Biotechnol J; 2006 Mar; 1(3):282-8. PubMed ID: 16897708
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel kynurenine production-inhibiting benzenesulfonamide derivatives in cancer cells.
Nakano S; Takai K; Isaka Y; Takahashi S; Unno Y; Ogo N; Matsuno K; Takikawa O; Asai A
Biochem Biophys Res Commun; 2012 Mar; 419(3):556-61. PubMed ID: 22369947
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.
Di Pucchio T; Danese S; De Cristofaro R; Rutella S
Expert Opin Ther Pat; 2010 Feb; 20(2):229-50. PubMed ID: 20100004
[TBL] [Abstract][Full Text] [Related]
8. Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells.
Malone DG; Dolan PW; Brown RR; Kalayoglu MV; Arend RA; Byrne GI; Ozaki Y
J Rheumatol; 1994 Jun; 21(6):1011-9. PubMed ID: 7523670
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of oren-gedoku-to and its components on cholesteryl ester synthesis in cultured human hepatocyte HepG2 cells: evidence from the cultured HepG2 cells and in vitro assay of ACAT.
Yotsumoto H; Yanagita T; Yamamoto K; Ogawa Y; Cha JY; Mori Y
Planta Med; 1997 Apr; 63(2):141-5. PubMed ID: 9140228
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.
Huang Q; Zheng M; Yang S; Kuang C; Yu C; Yang Q
Eur J Med Chem; 2011 Nov; 46(11):5680-7. PubMed ID: 21925773
[TBL] [Abstract][Full Text] [Related]
11. S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
Matsuno K; Takai K; Isaka Y; Unno Y; Sato M; Takikawa O; Asai A
Bioorg Med Chem Lett; 2010 Sep; 20(17):5126-9. PubMed ID: 20688518
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2.
Austin CJ; Mailu BM; Maghzal GJ; Sanchez-Perez A; Rahlfs S; Zocher K; Yuasa HJ; Arthur JW; Becker K; Stocker R; Hunt NH; Ball HJ
Amino Acids; 2010 Jul; 39(2):565-78. PubMed ID: 20140689
[TBL] [Abstract][Full Text] [Related]
13. Bimodal effect of nitric oxide in the enzymatic activity of indoleamine 2,3-dioxygenase in human monocytic cells.
López AS; Alegre E; Díaz A; Mugueta C; González A
Immunol Lett; 2006 Aug; 106(2):163-71. PubMed ID: 16797727
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
[TBL] [Abstract][Full Text] [Related]
15. Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.
Yue EW; Douty B; Wayland B; Bower M; Liu X; Leffet L; Wang Q; Bowman KJ; Hansbury MJ; Liu C; Wei M; Li Y; Wynn R; Burn TC; Koblish HK; Fridman JS; Metcalf B; Scherle PA; Combs AP
J Med Chem; 2009 Dec; 52(23):7364-7. PubMed ID: 19507862
[TBL] [Abstract][Full Text] [Related]
16. Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells.
Tourino MC; de Oliveira EM; Bellé LP; Knebel FH; Albuquerque RC; Dörr FA; Okada SS; Migliorini S; Soares IS; Campa A
Cell Biochem Funct; 2013 Jul; 31(5):361-4. PubMed ID: 23754498
[TBL] [Abstract][Full Text] [Related]
17. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
[TBL] [Abstract][Full Text] [Related]
18. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
[TBL] [Abstract][Full Text] [Related]
19. Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties.
Serra S; Moineaux L; Vancraeynest C; Masereel B; Wouters J; Pochet L; Frédérick R
Eur J Med Chem; 2014 Jul; 82():96-105. PubMed ID: 24878638
[TBL] [Abstract][Full Text] [Related]
20. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
